Andra söktjänster

English

Lars Franzen

Kontakt

lars.franzen@umu.se

Verksam vid

Anknuten som forskare till Institutionen för strålningsvetenskaper Enhet: Onkologi

27C, Målpunkt QC11, Norrlands universitetssjukhus Umeå universitet, 901 87 Umeå

Publikationer Publikationer

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial

The Lancet Oncology, Elsevier 2021, Vol. 22, (2) : 235-245

Fransson, Per; Nilsson, Per; Gunnlaugsson, Adalsteinn; et al.

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

The Lancet, Elsevier 2019, Vol. 394, (10196) : 385-395

Widmark, Anders; Gunnlaugsson, Adalsteinn; Beckman, Lars; et al.

Ultrahypofractionation for prostate cancer: Outcome from the Scandinavian phase 3 HYPO-RT-PC trial

Radiotherapy and Oncology, Elsevier 2018, Vol. 127 : S314-S314

Widmark, Anders; Gunnlaugsson, A.; Beckman, Lars; et al.

Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer: A five year follow up

Radiotherapy and Oncology, Vol. 118, (2) : 335-341

Nyqvist, Johanna; Fransson, Per; Laurell, Göran; et al.

Extreme Hypofractionation versus Conventionally Fractionated Radiotherapy for Intermediate Risk Prostate Cancer: Early Toxicity Results from the Scandinavian Randomized Phase III Trial "HYPO-RT-PC"

International Journal of Radiation Oncology, Biology, Physics, Elsevier 2016, Vol. 96, (5) : 938-939

Widmark, Anders; Gunnlaugsson, A.; Beckman, L.; et al.

Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN trial

Radiotherapy and Oncology, Vol. 117, (1) : 99-105

Zackrisson, Björn; Kjellén, Elisabeth; Söderström, Karin; et al.

Long-term safety and real world clinical experience of radium-223 dichloride (Ra-223) in patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets) from the phase 3 ALSYMPCA study

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 41, (suppl 2) : S271-S271

Franzen, Lars; Sartor, O.; Parker, C.; et al.

Two-Year Survival Follow-Up of the Randomized, Double-Blind, Placebo-Controlled Phase II Study of Radium-223 Chloride in Patients With Castration-Resistant Prostate Cancer and Bone Metastases

Clinical Genitourinary Cancer, Elsevier 2013, Vol. 11, (1) : 20-26

Nilsson, Sten; Franzén, Lars; Parker, Christopher; et al.

Effects of radium-223 dichloride (Ra-223) on health-related quality of life (QOL) outcomes in the phase 3 ALSYMPCA study in patients with castration-resistant prostate cancer (CRPC) and bone metastases

European Journal of Cancer, Elsevier 2013, Vol. 49, (Supplement 2) : S689-S689, Meeting Abstract: 2878

Parker, C.; Heinrich, D.; Bottomley, D.; et al.

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

New England Journal of Medicine, Vol. 369, (3) : 213-223

Parker, C.; Nilsson, S.; Heinrich, D.; et al.

A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer

European Journal of Cancer, Oxford: Elsevier 2012, Vol. 48, (5) : 678-686

Nilsson, S.; Strang, P.; Aksnes, A. K.; et al.

Secondary malignancies from prostate cancer radiation treatment: a risk analysis of the influence of target margins and fractionation patterns

International Journal of Radiation Oncology, Biology, Physics, Vol. 79, (3) : 738-746

Daşu, Alexandru; Toma-Daşu, Iuliana; Franzén, Lars; et al.

Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN study

Radiotherapy and Oncology, Elsevier 2011, Vol. 100, (1) : 41-48

Zackrisson, Björn; Nilsson, Per; Kjellén, Elisabeth; et al.

The risk of secondary cancers in patients treated for prostate carcinoma: an analysis with competition dose response model

IFMBE Proceedings, Berlin: Springer 2009 : 237-240

Dasu, Alexandru; Toma-Dasu, Iuliana; Franzen, Lars; et al.

The risk for secondary cancers in patients treated for prostate carcinoma: an analysis with completion dose response model

IFMBE Proceedings of the World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany, Springer Verlag 2009 : 237-240

Dasu, Alexandru; Toma-Dasu, Iuliana; Franzén, Lars; et al.

Boron neutron capture therapy (BNCT) for glioblastoma multiforme.: A phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).

Radiotherapy and Oncology, Vol. 88, (2) : 183-191

Henriksson, Roger; Capala, Jacek; Michanek, Annika; et al.

Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study.

The Lancet Oncology, Vol. 8, (7) : 587-594

Nilsson, Sten; Franzén, Lars; Parker, Christopher; et al.

Comparison of three instrumental methods for the objective evaluation of radiotherapy induced erythema in breast cancer patients and a study of the effect of skin lotions

Acta Oncologica, Oslo: Taylor & Francis 2007, Vol. 46, (7) : 893-899

Nyström, Josefina; Svensk, Ann-Christine; Lindholm-Sethson, Britta; et al.

Joint Center - samarbetsprojekt för optimal strålbehandling i närmiljö

Läkartidningen, Vol. 101, (6) : 472-475

Björeland, Anders; Blomquist, Michael; Sätherberg, Anders; et al.

Penis holder for external radiation treatment

Radiother Oncol, Vol. 71, (1) : 115-116

Löfroth, Per-Olov; Bergström, Per; Forsmark, Cenneth; et al.

Objective measurements of radiotherapy-induced erythema

Skin research and technology, Copenhagen: Munksgaard 2004, Vol. 10, (4) : 242-250

Nyström, Josefina; Geladi, Paul; Lindholm-Sethson, Britta; et al.

Early increase and later decrease in VIP and substance P nerve fiber densities following abdominal radiotherapy: a study on the human colon.

International Journal of Radiation Biology, Vol. 78, (11) : 1045-53

Höckerfelt, U; Franzén, L; Norrgård, O; et al.

Fractionated-irradiation and late changes in rat parotid-gland: effects on the number of acinar-cells, potassium efflux, and amylase secretion

International Journal of Radiation Biology, Vol. 64, (1) : 93-101

Franzén, Lars; Gustafsson, H; Sundström, S; et al.

Effects of fractionated irradiation on salivary glands

Umeå University medical dissertations, 330

Franzén, Lars

Fractionated irradiation and early changes in noradrenaline induced potassium efflux(86Rb+) in rat parotid gland

Acta Oncologica, Vol. 31, (3) : 359-364

Franzén, Lars; Sundström, Staffan; Karlsson, Mikael; et al.

Visa publikationer i DiVA